RWA
TNYA icon

Redhawk Wealth Advisors’s Tenaya Therapeutics TNYA Stock Holding History

Redhawk Wealth Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-65,350
Closed -$45.2K – 449
2026
Q1 		$45.2K Buy
+65,350
New +$48.2K 0.01% 382

Other funds holding TNYA

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Redhawk Wealth Advisors's TNYA Position: Q2 2026 in Review

Redhawk Wealth Advisors sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 65,350 shares — an estimated $45.2K sold.

Redhawk Wealth Advisors first reported a position in TNYA in Q1 2026 and held it in 1 quarter. The position peaked at $45.2K in Q1 2026. 9 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Redhawk Wealth Advisors reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 65,350 Tenaya Therapeutics shares in Q2 2026, an estimated $45.2K.
  • Redhawk Wealth Advisors first reported a position in Tenaya Therapeutics in Q1 2026 and held it in 1 quarter.
  • Redhawk Wealth Advisors's Tenaya Therapeutics position peaked at $45.2K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.